US FDA considers ways of regulating CBD

9 April 2019 - Deborah Wilkes

Archived

The US Food and Drug Administration (FDA) is holding a public hearing on potential ways of regulating products containing cannabis and cannabis-derived compounds including cannabidiol (CBD).

Click tags below for more information on topics:

CBD FDA CHPA

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: